Copyright
        ©The Author(s) 2020.
    
    
        World J Gastroenterol. Apr 28, 2020; 26(16): 1926-1937
Published online Apr 28, 2020. doi: 10.3748/wjg.v26.i16.1926
Published online Apr 28, 2020. doi: 10.3748/wjg.v26.i16.1926
            Table 1 Clinicopathological data of enrolled patients with Peutz-Jeghers syndrome
        
    | Case No. | Onset time of pigment spots (yr) | Gender | Family history or not (detail) | Load of gastric polyps | Maximum diameter of gastric polyps (mm) | Load of duodenal and small intestinal polyps | Maximum diameter of duodenal and small intestinal polyps (mm) | Load of colorectal polyps | Maximum diameter of colorectal polyps (mm) | Number of hospitalization times | Number of operation times | Number of intervention times | 
| 1 | 0 | Male | Yes (Father) | 0 | 0 | 1-10 | 30 | Unknown | Unknown | 1 | 1 | 3 | 
| 2 | 0 | Male | No | 1-10 | 10 | 31-40 | 80 | 11-20 | 70 | 3 | 1 | 4 | 
| 3 | 7 | Female | Yes (Father) | 1-10 | 6 | 21-30 | 25 | Unknown | Unknown | 1 | 1 | 4 | 
| 4 | 2 | Male | No | 11-20 | 17 | 1-10 | 25 | 1-10 | 40 | 1 | 1 | 4 | 
| 5 | 10 | Male | Yes (Son) | 1-10 | 5 | 51-60 | 50 | 41-50 | 25 | 5 | 3 | 12 | 
| 6 | 1 | Male | Yes (Mother) | 1-10 | 5 | 1-10 | 35 | 1-10 | 35 | 2 | 1 | 3 | 
| 7 | 1 | Male | No | 1-10 | 23 | 1-10 | 50 | Unknown | Unknown | 1 | 0 | 2 | 
| 8 | 1 | Male | Yes (Grandmother and mother) | 0 | 0 | Unknown | Unknown | 51-60 | 70 | 1 | 4 | 20 | 
| 9 | 7 | Male | Yes (Father) | 0 | 0 | 11-20 | 60 | 21-30 | 12 | 1 | 1 | 9 | 
| 10 | 13 | Female | No | 0 | 0 | 1-10 | 40 | 1-10 | 10 | 3 | 4 | 9 | 
| 11 | 2 | Male | No | 1-10 | 8 | 1-10 | 25 | 1-10 | 6 | 2 | 0 | 4 | 
| 12 | 0 | Female | No | 1-10 | 15 | 41-50 | 60 | 11-20 | 50 | 2 | 4 | 9 | 
| 13 | 5 | Female | Yes (Father and brother) | 21-30 | 15 | 41-50 | 60 | 21-30 | 60 | 4 | 2 | 9 | 
| 14 | 18 | Female | No | 21-30 | 5 | 11-20 | 30 | 1-10 | 6 | 2 | 1 | 5 | 
| 15 | 0.8 | Female | Yes (Father) | 1-10 | 6 | 1-10 | 6 | 0 | 0 | 2 | 0 | 4 | 
| 16 | 2 | Male | Yes (Father) | 21-30 | 20 | 31-40 | 45 | 51-60 | 45 | 2 | 7 | 21 | 
| 17 | 4 | Female | Yes (Son) | Unknown | Unknown | 21-30 | 30 | 1-10 | 30 | 1 | 1 | 5 | 
| 18 | 0 | Male | No | 1-10 | 15 | Unknown | Unknown | 1-10 | 20 | 1 | 0 | 2 | 
| 19 | 5 | Female | No | 0 | 0 | 11-20 | 20 | Unknown | Unknown | 1 | 2 | 7 | 
| 20 | 4 | Female | Yes (Sister) | 1-10 | 50 | 21-30 | 50 | Unknown | Unknown | 1 | 0 | 7 | 
            Table 2 Mutation status of LKB1/STK11 gene
        
    | Case No. | Allele | Mutation type | Exon/intron | Amino acid change | Base change | New mutation | 
| 1 | Heterozygosis | Missense | 4 | p.L167R | c.500T>G | No | 
| 2 | Heterozygosis | Nonsense | 1 | p.K84* | c.250A>T | No | 
| 3 | Heterozygosis | Frameshift deletion | 5 | p.A241Vfs*46 | c.722delC | Yes | 
| 4 | Homozygous | Frameshift insertion | 3 | p.Q152Pfs*11 | c.454_455insC | Yes | 
| 5 | Heterozygosis | Frameshift insertion | 1 | p.Y49Afs*4 | c.144_145insGCAAG | Yes | 
| 6 | Heterozygosis | Missense | 5 | p.S240W | c.719C>G | No | 
| 7 | Heterozygosis | Frameshift deletion | 1 | p.K82Rfs*14 | c.243delG | Yes | 
| 8 | Heterozygosis | Cleavage site | 5-61 | / | c.734+1G>A | Yes | 
| 10 | Heterozygosis | Cleavage site | 3-41 | / | c.464+1G>T | Yes | 
| 13 | Homozygous | Frameshift deletion | 3 | p.E145Gfs*10 | c.426_448delCGTGCCGGAGAAGCGTTTCCCAG | No | 
| 14 | Heterozygosis | Nonsense | 1 | p.K84* | c.250A>T | No | 
| 16 | Heterozygosis | Frameshift insertion | 1 | p.Y49Afs*4 | c.144_145insGCAAG | No | 
| 17 | Heterozygosis | Cleavage site | 4-51 | / | c.598-1G>A | Yes | 
| 18 | Heterozygosis | Nonsense | 1 | p.Y49* | c.147C>G | No | 
| 19 | Heterozygosis | Frameshift deletion | 2 | p.K122Afs*40 | c.363_364delGA | Yes | 
| 20 | Homozygosis | Cleavage site | 3-41 | / | c.464+1G>A | No | 
            Table 3 Prediction of protein function and amino acid evolution conservation of LKB1/STK11
        
    | Case No. | Polyphen-2 | Mutation taster | FATHMM | M-CAP | GERP++ | phyloP | ||||||
| Score | Prediction | Score | Prediction | Score | Prediction | Score | Prediction | Score | Prediction | Score | Prediction | |
| 1 | 1 | Probably damaging | 1 | Pathogenic | -2.5 | Damaging | 0.591 | Damaging | 5.6 | Conserved | 7.91 | Conserved | 
| 2 | / | / | 1 | Pathogenic | / | / | / | / | 3.9 | Conserved | 8.998 | Conserved | 
| 3 | / | / | 1 | Pathogenic | / | / | / | / | / | / | / | / | 
| 4 | / | / | 1 | Pathogenic | / | / | / | / | / | / | / | / | 
| 5 | / | / | 1 | Pathogenic | / | / | / | / | / | / | / | / | 
| 6 | 0.993 | Probably damaging | 1 | Pathogenic | -2.79 | Damaging | 0.704 | Damaging | 5.6 | Conserved | 7.799 | Conserved | 
| 7 | / | / | 1 | Pathogenic | / | / | / | / | / | / | / | / | 
| 8 | / | / | / | / | / | / | / | / | / | / | / | / | 
| 10 | / | / | / | / | / | / | / | / | / | / | / | / | 
| 13 | / | / | 1 | Pathogenic | / | / | / | / | / | / | / | / | 
| 14 | / | / | 1 | Pathogenic | / | / | / | / | 3.9 | Conserved | 8.998 | Conserved | 
| 16 | / | / | 1 | Pathogenic | / | / | / | / | / | / | / | / | 
| 17 | / | / | / | / | / | / | / | / | / | / | / | / | 
| 18 | / | / | 1 | Pathogenic | / | / | / | / | 3.9 | Conserved | 3.875 | Conserved | 
| 19 | / | / | 1 | Pathogenic | / | / | / | / | / | / | / | / | 
| 20 | / | / | / | / | / | / | / | / | / | / | / | / | 
            Table 4 Mutation of other 13 genes except LKB1/STK11 gene
        
    | Case No. | Gene | MMR | Type of mutation | Amino acid change | Base change | New mutation | 
| 3 | MUTYH | No | Missense | p.Ala373Val | c.1118C>T | No | 
| MLH1 | Yes | Missense | p.Val384Asp | c.1151T>A | No | |
| PMS2 | Yes | Missense | p.Thr511Met | c.1532C>T | No | |
| 4 | MSH6 | Yes | Missense | p.Ala1230Gly | c.3689C>G | Yes | 
| MLH1 | Yes | Missense | p.Val384Asp | c.1151T>A | No | |
| PMS2 | Yes | Missense | p.Thr511Met | c.1532C>T | No | |
| 7 | MLH3 | Yes | Non-synonymous SNV | p.Asp1081His | c.3241G>C | No | 
| AXIN2 | No | Non-synonymous SNV | p.Ser738Phe | c.2213C>T | No | |
| 9 | MSH6 | Yes | Missense | p.Glu1163Val | c.3488A>T | No | 
| APC | No | Missense | p.Met2221Thr | c.6662T>C | No | |
| 10 | MSH2 | Yes | Missense | p.Ile169Val | c.505A>G | No | 
| MSH6 | Yes | Intron insertion | / | c.4001+13C>CTTAC | Yes | |
| APC | No | Missense | p.Ala2778Ser | c.8332G>T | No | |
| 14 | MSH2 | Yes | Missense | p.Val89Ala | c.266T>C | No | 
| MSH2 | Yes | Cleavage site | / | c.792+1G>A | Yes | |
| PMS1 | Yes | Nonsense | p.Gln16Ter | c.46C>T | Yes | |
| PMS1 | Yes | Missense | p.Val308Ile | c.922G>A | Yes | |
| 15 | PTEN | No | Missense in 5 'untranslated region (UTR) | p.Gln171Glu | c.511C>G | No | 
| 19 | MSH2 | Yes | Missense | p.Leu390Phe | c.1168C>T | No | 
| 20 | MLH1 | Yes | Missense | p.Arg217Cys | c.649C>T | No | 
            Table 5 Prediction of protein function changes caused by MSH6 and other gene mutations
        
    | Case No. | Gene | Polyphen-2_HDIV | Mutation Taster | FATHMM | M-CAP | ||||
| Score | prediction | Score | Prediction | Score | Prediction | Score | Prediction | ||
| 3 | MUTYH | 0.069 | Benign | 1 | Pathogenic | -2.41 | Damaging | 0.084 | Damaging | 
| 3 | MLH1 | 1 | Probably_damaging | 1 | Pathogenic | -2.66 | Damaging | / | / | 
| 3 | PMS2 | 0.03 | Benign | 1 | Polymorphism | 1.06 | Tolerable | / | / | 
| 4 | MSH6 | 1 | Probably_damaging | 1 | Pathogenic | -2.52 | Damaging | 0.292 | Damaging | 
| 4 | MLH1 | 1 | Probably_damaging | 1 | Pathogenic | -2.66 | Damaging | / | / | 
| 4 | PMS2 | 0.239 | Benign | 1 | Polymorphism | 1.06 | Tolerable | / | / | 
| 7 | MLH3 | 1 | Probably_damaging | 1 | Pathogenic | -2.37 | Damaging | 0.137 | Damaging | 
| 7 | AXIN2 | 0.121 | Benign | 0.997 | Polymorphism | -0.25 | Tolerable | / | / | 
| 9 | MSH6 | 0.67 | Probably_damaging | 1 | Pathogenic | -2.12 | Damaging | / | / | 
| 9 | APC | 0.156 | Benign | 0.737 | Pathogenic | -2.47 | Damaging | 0.046 | Damaging | 
| 10 | MSH2 | 0 | Benign | 1 | Polymorphism | -2.29 | Damaging | 0.028 | Damaging | 
| 10 | MSH6 | / | / | / | / | / | / | / | / | 
| 10 | APC | 1 | Probably_damaging | 1 | Pathogenic | -1.53 | Damaging | 0.033 | Damaging | 
| 14 | MSH2 | 0.042 | Benign | 1 | Pathogenic | -2.47 | Damaging | 0.075 | Damaging | 
| 14 | MSH2 | / | / | / | / | / | / | / | / | 
| 14 | PMS1 | / | / | 1 | Pathogenic | / | / | / | / | 
| 14 | PMS1 | 0.329 | Benign | 0.996 | Pathogenic | -1.34 | Tolerable | 0.03 | Damaging | 
| 15 | PTEN | 0.956 | Probably_damaging | 0.999 | Pathogenic | / | / | / | / | 
| 19 | MSH2 | 0.148 | Benign | 1 | Pathogenic | -3.07 | Damaging | / | / | 
| 20 | MLH1 | 1 | Probably_damaging | 1 | Pathogenic | -1.91 | Damaging | 0.247 | Damaging | 
            Table 6 Prediction of amino acid evolutionary conservation due to mutations in MSH6 and other genes
        
    | Case No. | Gene | GERP++ | phyloP | ||
| Score | Prediction | Score | Prediction | ||
| 3 | MUTYH | 5.67 | Conserved | 6.955 | Conserved | 
| 3 | MLH1 | 5.67 | Conserved | 7.336 | Conserved | 
| 3 | PMS2 | -3.23 | Nonconserved | -0.25 | Nonconserved | 
| 4 | MSH6 | 5.5 | Conserved | 7.481 | Conserved | 
| 4 | MLH1 | 5.67 | Conserved | 7.336 | Conserved | 
| 4 | PMS2 | -3.23 | Nonconserved | -0.25 | Nonconserved | 
| 7 | MLH3 | 4.6 | Conserved | 5.502 | Conserved | 
| 7 | AXIN2 | 2.07 | Conserved | 2.225 | Conserved | 
| 9 | MSH6 | 5.23 | Conserved | 8.923 | Conserved | 
| 9 | APC | 6.02 | Conserved | 3.925 | Conserved | 
| 10 | MSH2 | -1.25 | Nonconserved | 1.857 | Nonconserved | 
| 10 | MSH6 | / | / | / | / | 
| 10 | APC | 5.92 | Conserved | 8.947 | Conserved | 
| 14 | MSH2 | 3.94 | Conserved | 3.331 | Conserved | 
| 14 | MSH2 | / | / | / | / | 
| 14 | PMS1 | 4.99 | Conserved | 7.805 | Conserved | 
| 14 | PMS1 | 2.11 | Conserved | 4.333 | Conserved | 
| 15 | PTEN | / | / | / | / | 
| 19 | MSH2 | 4.62 | Conserved | 1.611 | Nonconserved | 
| 20 | MLH1 | 5.76 | Conserved | 2.993 | Conserved | 
            Table 7 Relationship between gene mutation and clinical pathological parameters
        
    | Mutation | Result | Load of gastric polyps | Maximum diameter of gastric polyps (mm) | Load of duodenal and small intestinal polyps | Maximum diameter of duodenal and small intestinal polyps (mm) | Load of Colorectal polyps | Maximum diameter of colorectal polyps (mm) | Number of hospitalization times | Number of operation times | Number of intervention times | 
| LKB1/STK11 mutations | U value | 28.000 | 30.000 | 35.500 | 26.000 | 20.500 | 32.000 | 36.000 | 49.000 | 28.500 | 
| P value | 0.885 | 1.000 | 0.442 | 0.878 | 0.734 | 0.048 | 0.750 | 0.122 | 0.750 | |
| LKB1/STK11 truncating mutation | U value | 62.500 | 69.000 | 49.500 | 47.000 | 23.500 | 35.500 | 56.000 | 40.500 | 35.500 | 
| P value | 0.156 | 0.053 | 0.436 | 0.605 | 0.613 | 0.397 | 0.684 | 0.481 | 0.280 | |
| Other gene mutations | U value | 47.500 | 42.500 | 39.000 | 36.000 | 22.000 | 19.500 | 38.000 | 46.000 | 41.500 | 
| P value | 0.842 | 0.842 | 0.965 | 0.762 | 0.607 | 0.388 | 0.412 | 0.824 | 0.552 | 
- Citation: Zhang Z, Duan FX, Gu GL, Yu PF. Mutation analysis of related genes in hamartoma polyp tissue of Peutz-Jeghers syndrome. World J Gastroenterol 2020; 26(16): 1926-1937
 - URL: https://www.wjgnet.com/1007-9327/full/v26/i16/1926.htm
 - DOI: https://dx.doi.org/10.3748/wjg.v26.i16.1926
 
